READY TO UPGRADE
TO THE NEW MINIMED^™ 770G SYSTEM USING
NEXT TECH PATHWAY?

Get Notified.

Fill out your contact information below so that we can reach out to provide more information on how to redeem your Next Tech Pathway.

I have read and understand the terms of this marketing authorization. I hereby knowingly and voluntarily authorize Medtronic to use such information for the purposes described in the authorization.

AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.

This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.

You have the right to revoke this authorization at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.

You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.

Questions? Contact our Customer Service Center at 800-646-4633, or by email at takecontrol@medtronic.com.

I have read and understand the terms of this phone communications. I consent to receive phone calls and/or artificial or prerecorded voice messages at the phone number(s) provided above sent from or on behalf of Medtronic Diabetes using automated technology.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

I have read and understand the terms of this text communications. I consent to receive text communications at the mobile phone number provided above using automated technology sent from or on behalf of Medtronic Diabetes (message frequency may vary).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

Sage
Wearing the MiniMed^™ 670G system

WHAT IS THE NEXT TECH
PATHWAY PROGRAM?

Those who purchased a MiniMed^™ 670G system after 11/7/19 will automatically be entered into the Next Tech Pathway program. This program allows you to access the MiniMed^™ 770G for $0. The order must be shipped no later than 9/1/21.^† See program terms and conditions for full details.

Program terms & conditions

TECHNOLOGY THAT ADAPTS TO YOU

The MiniMed^™ 770G insulin pump system automatically adjusts background insulin every 5 minutes.^* Using real-time glucose readings, the system is able to calculate a personalized amount of insulin to deliver based on your needs. The system connects directly with a smart device, allowing you to view sugar trends and insulin data on the go.

System parts Features & benefits View specs Therapy for children

HOW DO I REDEEM MY NEW TECHNOLOGY FOR $0?

Sign-in to your Account - https://www.diabetes.shop/devices
Under Devices and products, select the “Check upgrade eligibility” button

Check upgrade eligibility screen

NOT PART OF NEXT TECH PATHWAY?

We have other upgrade programs available now for those using an in-warranty pump. Learn more.

Frequently Asked Questions

When can I redeem the Next Tech Pathway to upgrade to a new pump?

During your warranty period, with more than 6 months left, you will have a one-time opportunity to upgrade to the MiniMed^™ 770G system for $0.

How do I redeem the Next Tech Pathway and how much will it cost?

To redeem your Next Tech Pathway, sign-in to your Account. Under Devices and products, select the “Check upgrade eligibility” button. You may also redeem by calling us at 877-585-0208. Specialists are available from 8AM-6PM CT. The total out-of-pocket cost to purchase the MiniMed™ 770G system using the Next Tech Pathway is $0.

How often can I upgrade using the Next Tech Pathway program?

The Next Tech Pathway program is a one-time in-warranty upgrade to the MiniMed^™ 770G system. Order must be shipped no later than 9/1/21.

Will my pump Replacement warranty reset after upgrading using the Next Tech Pathway program?

No, Replacement warranty dates do not reset. The warranty date of an upgraded insulin pump will remain the same as the warranty date of the initial pump purchased.

What if I do not return my old insulin pump and transmitter within 90 days?

The $0 price will be honored if you comply with program terms. If you do not return your old insulin pump within 90 days, you will be charged $3,200.

What happens if I am already on the latest MiniMed^™ insulin pump system (purchased before the launch of this program)?

You can still access future technology through our Pathway program. For more information: click here.

References

* Refers to SmartGuard^™ Auto Mode. Some user interaction required. Individual results may vary.

^† Next Tech Pathway Program Terms & Conditions
The Next Tech Pathway program (the “Program”) allows eligible, enrolled participants whose MiniMed^™ 670G system order is shipped starting on 11/7/19 to be included. The last day to place an order is 12/1/20. This Program allows for an upgrade to our next MiniMed^™ system at $0. Eligibility dates subject to change.

To be eligible for the Program, participants must purchase a MiniMed™ 670G system and meet one of the following requirements:

New to Medtronic insulin pump therapy
Upgrade from an out-of-warranty pump

This program is not available to customers on a rental program such as those enrolled in federal, state, or other government-funded healthcare program like Medicare, Medicare Advantage, Medicaid, Medigap, the Department of Defense (“DoD”) or TRICARE.

To upgrade through the Program, all participants must agree and are subject to these terms and conditions:

Return of old MiniMed^™ 670G insulin pump is required. If the old pump is not returned within 90 days, you will be charged $3,200.
Replacement warranty period does not reset when you receive the new technology. The warranty period of an upgraded insulin pump and transmitter will remain the same as the warranty date of the initial pump and transmitter purchased.
MiniMed^™ pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider.
Upon first commercial shipping of a new MiniMed^™ system, it may take up to 90 days for Medtronic to contact you with the option to upgrade. Once you place your order, it may take up to 90 days to ship the new product. The Program does not guarantee prioritization of your order.
An upgrade through the Program can only be redeemed once during your warranty period for the next available technology and customers’ order must ship no later than 9/1/21. The Program cannot be redeemed if less than six (6) months remains on your pump warranty.
The Program for the future upgrade applies to one (1) in-warranty insulin pump and one (1) in-warranty transmitter. CGM sensors and consumables are not included, however, these Medtronic products will remain compatible.
If transmitter is out of warranty, customer will need to purchase a new transmitter.
Insurance coverage and plan design varies and may impact the ability to upgrade. Coverage is contingent upon your health insurance medical policy guidelines. Restrictions and medical necessity requirements may apply.
A valid prescription will be required to purchase a new pump. All participants should consult their healthcare provider for all therapy related decisions.
Program terms and conditions are subject to change at any time and without notice. Other restrictions may apply.

Important Safety Information: MiniMed^™ 770G System With SmartGuard^™ Technology

The MiniMed^™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed^™ 770G System includes SmartGuard^™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. The Medtronic MiniMed^™ 770G System consists of the following devices: MiniMed^™ 770G Insulin Pump, the Guardian^™ Link (3) Transmitter, the Guardian^™ Sensor (3), one-press serter, the Accu-Chek^® Guide Link blood glucose meter, and the Accu-Chek^® Guide Test Strips. The system requires a prescription.The Guardian^™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian^™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek^® Guide Link blood glucose meter and not on values provided by the Guardian^™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek^® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard^™ Auto Mode for people who require less than eight units or more than 250 units of total daily insulin per day. A total daily dose of at least eight units, but no more than 250 units, is required to operate in SmartGuard^™ Auto Mode.

WARNING: Do not use the MiniMed^™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed^™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed^™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library